Old fashioned vs. Ultra-processed-based current diets: Possible implication in the increased susceptibility to type 1 diabetes and celiac disease in childhood

Foods

Volumn 6, Issue 11, 2017, Pages

  Aguayo Patrón, Sandra V ^a   Calderón de la Barca, Ana M ^a  

^a CENTRO DE INVESTIGACIÓN EN ALIMENTACIÓN Y DESARROLLO   (Mexico)

Author keywords

Autoimmunity risk; Celiac disease; Microbiota; Type 1 diabetes; Ultra processed food products

Indexed keywords

EID: 85053806157     PISSN: None     EISSN: 23048158     Source Type: Journal    
DOI: 10.3390/foods6110100     Document Type: Review

References (87)

1. American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care 2017, 40 (Suppl. 1), S11–S24. [CrossRef]
2. Ludvigsson, J.F.; Leffler, D.A.; Bai, J.C.; Biagi, F.; Fasano, A.; Green, P.H.; Hadjivassiliou, M.; Kaukinen, K.; Kelly, C.P.; Leonard, J.N.; et al. The Oslo definitions for coeliac disease and related terms. Gut 2013, 62, 43–52. [CrossRef] [PubMed]
3. Pettitt, D.J.; Talton, J.; Dabelea, D.; Divers, J.; Imperatore, G.; Lawrence, J.M.; Liese, A.D.; Linder, B.; Mayer-Davis, E.J.; Pihoker, C.; et al. Prevalence of diabetes in U.S. youth in 2009: The SEARCH for diabetes in youth study. Diabetes Care 2014, 37, 402–408. [CrossRef] [PubMed]
4. Ludvigsson, J.F.; Rubio-Tapia, A.; van Dyke, C.T.; Melton, L.J.; Zinsmeister, A.R.; Lahr, B.D.; Murray, J.A. Increasing incidence of celiac disease in a North American population. Am. J. Gastroenterol. 2013, 108, 818–824. [CrossRef] [PubMed]
5. Namatovu, F.; Sandström, O.; Olsson, C.; Lindkvist, M.; Ivarsson, A. Celiac disease risk varies between birth cohorts, generating hypotheses about causality: Evidence from 36 years of population-based follow-up. BMC Gastroenterol. 2014, 14, 59–66. [CrossRef] [PubMed]
6. Fazeli Farsani, S.; Souverein, P.C.; van der Vorst, M.M.; Knibbe, C.A.; Herings, R.M.; de Boer, A.; Mantel-Teeuwisse, A.K. Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the Netherlands. Pediatr. Diabetes 2016, 17, 44–52. [CrossRef] [PubMed]
7. Hu, Y.; Wong, F.S.; Wen, L. Antibiotics, gut microbiota, environment in early life and type 1 diabetes. Pharmacol. Res. 2017, 119, 219–226. [CrossRef] [PubMed]
8. Verdu, E.F.; Galipeau, H.J.; Jabri, B. Novel players in coeliac disease pathogenesis: Role of the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 497–506. [CrossRef] [PubMed]
9. Knip, M.; Siljander, H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2016, 12, 154–167. [CrossRef] [PubMed]
10. Gensollen, T.; Iyer, S.S.; Kasper, D.L.; Blumberg, R.S. How colonization by microbiota in early life shapes the immune system. Science 2016, 352, 539–544. [CrossRef] [PubMed]
11. Endesfelder, D.; Engel, M.; Davis-Richardson, A.G.; Ardissone, A.N.; Achenbach, P.; Hummel, S.; Winkler, C.; Atkinson, M.; Schatz, D.; Triplett, E.; et al. Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome 2016, 4, 17–28. [CrossRef] [PubMed]
12. Wu, G.D.; Chen, J.; Hoffmann, C.; Bittinger, K.; Chen, Y.Y.; Keilbaugh, S.A.; Bewtra, M.; Knights, D.; Walters, W.A.; Knight, R.; et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334, 105–108. [CrossRef] [PubMed]
13. David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.; et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559–563. [CrossRef] [PubMed]
14. Davis-Richardson, A.G.; Triplett, E.W. A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia 2015, 58, 1386–1393. [CrossRef] [PubMed]
15. Monteiro, C.A.; Levy, R.B.; Claro, R.M.; Castro, I.R.; Cannon, G. A new classification of foods based on the extent and purpose of their processing. Cad. Saude Publica 2010, 26, 2039–2049. [CrossRef] [PubMed]
16. Monteiro, C.A.; Moubarac, J.C.; Levy, R.B.; Canella, D.S.; Louzada, M.L.D.C.; Cannon, G. Household availability of ultra-processed foods and obesity in nineteen European countries. Public Health Nutr. 2017, in press. [CrossRef] [PubMed]
17. Mejía-León, M.E.; Calderón de la Barca, A.M. Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution. Nutrients 2015, 7, 9171–9184. [CrossRef] [PubMed]
18. Mejía-León, M.E.; Petrosino, J.F.; Ajami, N.J.; Domínguez-Bello, M.G.; Calderón de la Barca, A.M. Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci. Rep. 2014, 4, 3814. [CrossRef] [PubMed]
19. Ríos-Covián, D.; Ruas-Madiedo, P.; Margolles, A.; Gueimonde, M.; de Los Reyes-Gavilán, C.G.; Salazar, N. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front. Microbiol. 2016, 7, 185. [CrossRef] [PubMed]
20. Vaarala, O. Is the origin of type 1 diabetes in the gut? Immunol. Cell Biol. 2012, 90, 271–276. [CrossRef] [PubMed]
21. Alkanani, A.K.; Hara, N.; Gottlieb, P.A.; Ir, D.; Robertson, C.E.; Wagner, B.D.; Frank, D.N.; Zipris, D. Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes. Diabetes 2015, 64, 3510–3520. [CrossRef] [PubMed]
22. De Goffau, M.C.; Luopajärvi, K.; Knip, M.; Ilonen, J.; Ruohtula, T.; Härkönen, T.; Orivuori, L.; Hakala, S.; Welling, G.W.; Harmsen, H.J.; et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013, 62, 1238–1244. [CrossRef] [PubMed]
23. Davis-Richardson, A.G.; Ardissone, A.N.; Dias, R.; Simell, V.; Leonard, M.T.; Kemppainen, K.M.; Drew, J.C.; Schatz, D.; Atkinson, M.A.; Kolaczkowski, B.; et al. Bacteroides. dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front. Microbiol. 2014, 5, 678. [CrossRef] [PubMed]
24. Vehik, K.; Lynch, K.F.; Schatz, D.A.; Akolkar, B.; Hagopian, W.; Rewers, M.; She, J.X.; Simell, O.; Toppari, J.; Ziegler, A.G.; et al. Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study. Diabetes Care 2016, 39, 1535–1542. [CrossRef] [PubMed]
25. Viggiano, D.; Ianiro, G.; Vanella, G.; Bibbò, S.; Bruno, G.; Simeone, G.; Mele, G. Gut barrier in health and disease: Focus on childhood. Eur. Rev. Med. Pharmacol. Sci. 2015, 19, 1077–1085. [PubMed]
26. Collado, M.C.; Donat, E.; Ribes-Koninckx, C.; Calabuig, M.; Sanz, Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J. Clin. Pathol. 2009, 62, 264–269. [CrossRef] [PubMed]
27. Di Cagno, R.; De Angelis, M.; De Pasquale, I.; Ndagijimana, M.; Vernocchi, P.; Ricciuti, P.; Gagliardi, F.; Laghi, L.; Crecchio, C.; Guerzoni, M.E.; et al. Duodenal and faecal microbiota of celiac children: Molecular, phenotype and metabolome characterization. BMC Microbiol. 2011, 11, 219. [CrossRef] [PubMed]
28. Sánchez, E.; Laparra, J.M.; Sanz, Y. Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl. Environ. Microbiol. 2012, 78, 6507–6515. [CrossRef] [PubMed]
29. D’Argenio, V.; Casaburi, G.; Precone, V.; Pagliuca, C.; Colicchio, R.; Sarnataro, D.; Discepolo, V.; Kim, S.M.; Russo, I.; Del Vecchio Blanco, G.; et al. Metagenomics Reveals Dysbiosis and a Potentially Pathogenic N. flavescens Strain in Duodenum of Adult Celiac Patients. Am. J. Gastroenterol. 2016, 111, 879–890. [CrossRef] [PubMed]
30. Estévez, V.; Ayala, J.; Vespa, C.; Araya, M. The gluten-free basic food basket: A problem of availability, cost and nutritional composition. Eur. J. Clin. Nutr. 2016, 70, 1215–1217. [CrossRef] [PubMed]
31. Mazzeo, T.; Cauzzi, S.; Brighenti, F.; Pellegrini, N. The development of a composition database of gluten-free products. Public Health Nutr. 2015, 18, 1353–1357. [CrossRef] [PubMed]
32. Missbach, B.; Schwingshackl, L.; Billmann, A.; Mystek, A.; Hickelsberger, M.; Bauer, G.; König, J. Gluten-free food database: The nutritional quality and cost of packaged gluten-free foods. PeerJ 2015, 3, e1337. [CrossRef] [PubMed]
33. Moubarac, J.C.; Batal, M.; Martins, A.P.; Claro, R.; Levy, R.B.; Cannon, G.; Monteiro, C. Processed and ultra-processed food products: Consumption trends in Canada from 1938 to 2011. Can. J. Diet. Pract. Res. 2014, 75, 15–21. [CrossRef] [PubMed]
34. Djupegot, I.L.; Nenseth, C.B.; Bere, E.; Bjørnarå, H.B.T.; Helland, S.H.; Øverby, N.C.; Torstveit, M.K.; Stea, T.H. The association between time scarcity, sociodemographic correlates and consumption of ultra-processed foods among parents in Norway: A cross-sectional study. BMC Public Health 2017, 17, 447. [CrossRef] [PubMed]
35. Pan American Health Organization; World Health Organization regional office for the Americas. Ultra-Processed Food and Drink Products in Latin America: Trends, Impact on Obesity, Policy Implications; PAHO: Washington, DC, USA, 2015.
36. Fardet, A. Minimally processed foods are more satiating and less hyperglycemic than ultra-processed foods: A preliminary study with 98 ready-to-eat foods. Food Funct. 2016, 7, 2338–2346. [CrossRef] [PubMed]
37. Moubarac, J.C.; Batal, M.; Louzada, M.L.; Martinez Steele, E.; Monteiro, C.A. Consumption of ultra-processed foods predicts diet quality in Canada. Appetite 2017, 108, 512–520. [CrossRef] [PubMed]
38. Martins, A.P.; Levy, R.B.; Claro, R.M.; Moubarac, J.C.; Monteiro, C.A. Increased contribution of ultra-processed food products in the Brazilian diet (1987–2009). Rev. Saude Publica 2013, 47, 656–665. [CrossRef] [PubMed]
39. Mendonça, R.D.; Lopes, A.C.; Pimenta, A.M.; Gea, A.; Martinez-Gonzalez, M.A.; Bes-Rastrollo, M. Ultra-Processed Food Consumption and the Incidence of Hypertension in a Mediterranean Cohort: The Seguimiento Universidad de Navarra Project. Am. J. Hypertens. 2017, 30, 358–366. [CrossRef] [PubMed]
40. Giménez, A.; Saldamando, L.; Curutchet, M.R.; Ares, G. Package design and nutritional profile of foods targeted at children in supermarkets in Montevideo, Uruguay. Cad. Saude Publica 2017, 33, e00032116. [CrossRef] [PubMed]
41. Karnopp, E.V.; Vaz, J.D.; Schafer, A.A.; Muniz, L.C.; Souza, R.L.; Santos, I.D.; Gigante, D.P.; Assunção, M.C. Food consumption of children younger than 6 years according to the degree of food processing. J. Pediatr. (Rio J.) 2017, 93, 70–78. [CrossRef] [PubMed]
42. Tavares, L.F.; Fonseca, S.C.; Garcia Rosa, M.L.; Yokoo, E.M. Relationship between ultra-processed foods and metabolic syndrome in adolescents from a Brazilian Family Doctor Program. Public Health Nutr. 2012, 15, 82–87. [CrossRef] [PubMed]
43. Rauber, F.; Campagnolo, P.D.; Hoffman, D.J.; Vitolo, M.R. Consumption of ultra-processed food products and its effects on children’s lipid profiles: A longitudinal study. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 116–122. [CrossRef] [PubMed]
44. Wilkin, T.J. The convergence of type 1 and type 2 diabetes in childhood: The accelerator hypothesis. Pediatr. Diabetes 2012, 13, 334–339. [CrossRef] [PubMed]
45. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P.; et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222–227. [CrossRef] [PubMed]
46. De Filippo, C.; Cavalieri, D.; Di Paola, M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 2010, 107, 14691–14696. [CrossRef] [PubMed]
47. Chassaing, B.; Van de Wiele, T.; Gewirtz, A. Dietary Emulsifiers Directly Impact the Human Gut Microbiota Increasing Its Pro-inflammatory Potential and Ability to Induce Intestinal Inflammation. Inflamm. Bowel Dis. 2017, 23, S5.
48. Liu, Z.; Roy, N.C.; Guo, Y.; Jia, H.; Ryan, L.; Samuelsson, L.; Thomas, A.; Plowman, J.; Clerens, S.; Day, L.; et al. Human Breast Milk and Infant Formulas Differentially Modify the Intestinal Microbiota in Human Infants and Host Physiology in Rats. J. Nutr. 2016, 146, 191–199. [CrossRef] [PubMed]
49. Kashtanova, D.A.; Popenko, A.S.; Tkacheva, O.N.; Tyakht, A.B.; Alexeev, D.G.; Boytsov, S.A. Association between the gut microbiota and diet: Fetal life, early childhood, and further life. Nutrition 2016, 32, 620–627. [CrossRef] [PubMed]
50. Wopereis, H.; Oozeer, R.; Knipping, K.; Belzer, C.; Knol, J. The first thousand days—Intestinal microbiology of early life: Establishing a symbiosis. Pediatr. Allergy Immunol. 2014, 25, 428–438. [CrossRef] [PubMed]
51. Jiminez, J.A.; Uwiera, T.C.; Abbott, D.W.; Uwiera, R.R.; Inglis, G.D. Impacts of resistant starch and wheat bran consumption on enteric inflammation in relation to colonic bacterial community structures and short-chain fatty acid concentrations in mice. Gut Pathog. 2016, 8, 67. [CrossRef] [PubMed]
52. Upadhyaya, B.; McCormack, L.; Fardin-Kia, A.R.; Juenemann, R.; Nichenametla, S.; Clapper, J.; Specker, B.; Dey, M. Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions. Sci. Rep. 2016, 6, 28797. [CrossRef] [PubMed]
53. Hald, S.; Schioldan, A.G.; Moore, M.E.; Dige, A.; Lærke, H.N.; Agnholt, J.; Bach Knudsen, K.E.; Hermansen, K.; Marco, M.L.; Gregersen, S.; et al. Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study. PLoS ONE 2016, 11, e0159223. [CrossRef] [PubMed]
54. Martínez Steele, E.; Baraldi, L.G.; Louzada, M.L.; Moubarac, J.C.; Mozaffarian, D.; Monteiro, C.A. Ultra-processed foods and added sugars in the US diet: Evidence from a nationally representative cross-sectional study. BMJ Open 2016, 6, e009892. [CrossRef] [PubMed]
55. Noble, E.E.; Hsu, T.M.; Jones, R.B.; Fodor, A.A.; Goran, M.I.; Kanoski, S.E. Early-Life Sugar Consumption Affects the Rat Microbiome Independently of Obesity. J. Nutr. 2017, 147, 20–28. [CrossRef] [PubMed]
56. Nakayama, J.; Yamamoto, A.; Palermo-Conde, L.A.; Higashi, K.; Sonomoto, K.; Tan, J.; Lee, Y.K. Impact of Westernized Diet on Gut Microbiota in Children on Leyte Island. Front. Microbiol. 2017, 8, 197. [CrossRef] [PubMed]
57. Schoen, S.; Jergens, S.; Barbaresko, J.; Nöthlings, U.; Kersting, M.; Remer, T.; Stelmach-Mardas, M.; Ziegler, A.G.; Hummel, S. Diet Quality during Infancy and Early Childhood in Children with and without Risk of Type 1 Diabetes: A DEDIPAC Study. Nutrients 2017, 9, 48. [CrossRef] [PubMed]
58. Weber, K.S.; Raab, J.; Haupt, F.; Aschemeier, B.; Wosch, A.; Ried, C.; Kordonouri, O.; Ziegler, A.G.; Winkler, C. Evaluating the diet of children at increased risk for type 1 diabetes: First results from the TEENDIAB study. Public Health Nutr. 2015, 18, 50–58. [CrossRef] [PubMed]
59. Lamb, M.M.; Frederiksen, B.; Seifert, J.A.; Kroehl, M.; Rewers, M.; Norris, J.M. Sugar intake is associated with progression from islet autoimmunity to type 1 diabetes: The Diabetes Autoimmunity Study in the Young. Diabetologia 2015, 58, 2027–2034. [CrossRef] [PubMed]
60. Byerley, L.O.; Samuelson, D.; Blanchard, E.; Luo, M.; Lorenzen, B.N.; Banks, S.; Ponder, M.A.; Welsh, D.A.; Taylor, C.M. Changes in the gut microbial communities following addition of walnuts to the diet. J. Nutr. Biochem. 2017, 48, 94–102. [CrossRef] [PubMed]
61. Robertson, R.C.; Seira Oriach, C.; Murphy, K.; Moloney, G.M.; Cryan, J.F.; Dinan, T.G.; Paul Ross, R.; Stanton, C. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav. Immun. 2017, 59, 21–37. [CrossRef] [PubMed]
62. Noriega, B.S.; Sanchez-Gonzalez, M.A.; Salyakina, D.; Coffman, J. Understanding the Impact of Omega-3 Rich Diet on the Gut Microbiota. Case Rep. Med. 2016, 2016, 3089303. [CrossRef] [PubMed]
63. Bi, X.; Li, F.; Liu, S.; Jin, Y.; Zhang, X.; Yang, T.; Dai, Y.; Li, X.; Zhao, A.Z. ω-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity. J. Clin. Investig. 2017, 127, 1757–1771. [CrossRef] [PubMed]
64. Bergamo, P.; Palmieri, G.; Cocca, E.; Ferrandino, I.; Gogliettino, M.; Monaco, A.; Maurano, F.; Rossi, M. Adaptive response activated by dietary cis9, trans11 conjugated linoleic acid prevents distinct signs of gliadin-induced enteropathy in mice. Eur. J. Nutr. 2016, 55, 729–740. [CrossRef] [PubMed]
65. Onishi, J.C.; Campbell, S.; Moreau, M.; Patel, F.; Brooks, A.I.; Zhou, Y.X.; Häggblom, M.M.; Storch, J. Bacterial communities in the small intestine respond differently to those in the caecum and colon in mice fed low-and high-fat diets. Microbiology 2017, 163, 1189–1197. [CrossRef] [PubMed]
66. Agus, A.; Denizot, J.; Thévenot, J.; Martinez-Medina, M.; Massier, S.; Sauvanet, P.; Bernalier-Donadille, A.; Denis, S.; Hofman, P.; Bonnet, R.; et al. Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation. Sci. Rep. 2016, 6, 19032. [CrossRef] [PubMed]
67. Shankar, V.; Gouda, M.; Moncivaiz, J.; Gordon, A.; Reo, N.V.; Hussein, L.; Paliy, O. Differences in Gut Metabolites and Microbial Composition and Functions between Egyptian and U.S. Children Are Consistent with Their Diets. mSystems 2017, 2, e00169-16. [CrossRef] [PubMed]
68. Santarpia, L.; Contaldo, F.; Pasanisi, F. Dietary protein content for an optimal diet: A clinical view. J. Cachexia Sarcopenia Muscle 2017, 8, 345–348. [CrossRef] [PubMed]
69. Zhu, Y.; Lin, X.; Zhao, F.; Shi, X.; Li, H.; Li, Y.; Zhu, W.; Xu, X.; Li, C.; Zhou, G. Meat, dairy and plant proteins alter bacterial composition of rat gut bacteria. Sci. Rep. 2015, 5, 15220. [CrossRef] [PubMed]
70. Wang, W.; Wu, H.W.; Liu, J.F. Cow milk induced allergies (CMA) and asthma in new born. Eur. Rev. Med. Pharmacol. Sci. 2016, 20, 1008–1014. [PubMed]
71. Knip, M.; Virtanen, S.M.; Seppä, K.; Ilonen, J.; Savilahti, E.; Vaarala, O.; Reunanen, A.; Teramo, K.; Hämäläinen, A.M.; Paronen, J.; et al. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N. Engl. J. Med. 2010, 363, 1900–1908. [CrossRef] [PubMed]
72. Vaarala, O.; Knip, M.; Paronen, J.; Hämäläinen, A.M.; Muona, P.; Väätäinen, M.; Ilonen, J.; Simell, O.; Akerblom, H.K. Cow’s milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 1999, 48, 1389–1394. [CrossRef] [PubMed]
73. Trinchese, G.; Cavaliere, G.; Canani, R.B.; Matamoros, S.; Bergamo, P.; De Filippo, C.; Aceto, S.; Gaita, M.; Cerino, P.; Negri, R.; et al. Human, donkey and cow milk differently affects energy efficiency and inflammatory state by modulating mitochondrial function and gut microbiota. J. Nutr. Biochem. 2015, 26, 1136–1146. [CrossRef] [PubMed]
74. Calderón de la Barca, A.M.; Mejía-León, M.E. Are Gluten-Free Foods Just for Patients with a Gluten-Related Disease? In Celiac Disease and Non-Celiac Gluten Sensitivity, 1st ed.; Rodrigo, L., Ed.; InTech: Rijeka, Croatia, 2017; pp. 59–72.
75. Alzaben, A.S.; Turner, J.; Shirton, L.; Samuel, T.M.; Persad, R.; Mager, D. Assessing Nutritional Quality and Adherence to the Gluten-free Diet in Children and Adolescents with Celiac Disease. Can. J. Diet. Pract. Res. 2015, 76, 56–63. [CrossRef] [PubMed]
76. Anania, C.; Pacifico, L.; Olivero, F.; Perla, F.M.; Chiesa, C. Cardiometabolic risk factors in children with celiac disease on a gluten-free diet. World J. Clin. Pediatr. 2017, 6, 143–148. [CrossRef] [PubMed]
77. De Palma, G.; Nadal, I.; Collado, M.C.; Sanz, Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br. J. Nutr. 2009, 102, 1154–1160. [CrossRef] [PubMed]
78. Caminero, A.; Nistal, E.; Arias, L.; Vivas, S.; Comino, I.; Real, A.; Sousa, C.; de Morales, J.M.; Ferrero, M.A.; Rodríguez-Aparicio, L.B.; et al. A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity. Eur. J. Nutr. 2012, 51, 293–299. [CrossRef] [PubMed]
79. World Health Organization. Infant and Young Child Nutrition. Global Strategy on Infant and Young Child Feeding. Fifty-fifth World Health Assembly. 2002. Available online: http://apps.who.int/gb/archive/pdf_ files/WHA55/ea5515.pdf?ua=1 (accessed on 13 October 2017).
80. Lerner, A.; Matthias, T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun. Rev. 2015, 14, 479–489. [CrossRef] [PubMed]
81. Csáki, K.F. Synthetic surfactant food additives can cause intestinal barrier dysfunction. Med. Hypotheses 2011, 76, 676–681. [CrossRef] [PubMed]
82. Chassaing, B.; Koren, O.; Goodrich, J.K.; Poole, A.C.; Srinivasan, S.; Ley, R.E.; Gewirtz, A.T. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015, 519, 92–96. [CrossRef] [PubMed]
83. Swidsinski, A.; Ung, V.; Sydora, B.C.; Loening-Baucke, V.; Doerffel, Y.; Verstraelen, H.; Fedorak, R.N. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm. Bowel Dis. 2009, 15, 359–364. [CrossRef] [PubMed]
84. Shah, R.; Kolanos, R.; DiNovi, M.J.; Mattia, A.; Kaneko, K.J. Dietary exposures for the safety assessment of seven emulsifiers commonly added to foods in the United States and implications for safety. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2017, 34, 905–917. [CrossRef] [PubMed]
85. Avila-Nava, A.; Noriega, L.G.; Tovar, A.R.; Granados, O.; Perez-Cruz, C.; Pedraza-Chaverri, J.; Torres, N. Food combination based on a pre-hispanic Mexican diet decreases metabolic and cognitive abnormalities and gut microbiota dysbiosis caused by a sucrose-enriched high-fat diet in rats. Mol. Nutr. Food Res. 2017, 61, 1501023. [CrossRef] [PubMed]
86. Gutiérrez-Díaz, I.; Fernández-Navarro, T.; Sánchez, B.; Margolles, A.; González, S. Mediterranean diet and faecal microbiota: A transversal study. Food Funct. 2016, 7, 2347–2356. [CrossRef] [PubMed]
87. Glick-Bauer, M.; Yeh, M.C. The health advantage of a vegan diet: Exploring the gut microbiota connection. Nutrients 2014, 6, 4822–4838. [CrossRef] [PubMed]